Close Menu

NEW YORK – GenomSys, a startup maker of DNA data processing software based in Switzerland, said today that it has closed a CHF 9.3 million ($9.3 million) Series A investment round. 

Geneva-based Preon Capital led the round, with participation from several European and American partners, including Elysia Capital, Dolby Family Ventures, and Susman Ventures. As a result of the investment, Dolby Family Ventures Managing Director Pascal Levensohn has joined the GenomSys board of directors.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

A tissue sample from the 1960s harbors a near-complete sample of HIV, IFLScience reports.

A new bill would reshape the US National Science Foundation to include a focus on technological development, according to Science.

The Food and Drug Administration's decision to halt a SARS-CoV-2 study has drawn criticism, according to Stat News.

In Genome Biology this week: features affecting gut microbiome and parasite patterns, cellular interactions in lung tumor microenvironment, and more.